Correlation Between Abiomed and Alx Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abiomed and Alx Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abiomed and Alx Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abiomed and Alx Oncology Holdings, you can compare the effects of market volatilities on Abiomed and Alx Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abiomed with a short position of Alx Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abiomed and Alx Oncology.

Diversification Opportunities for Abiomed and Alx Oncology

  Correlation Coefficient

Average diversification

The 3 months correlation between Abiomed and Alx Oncology is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Abiomed and Alx Oncology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alx Oncology Holdings and Abiomed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abiomed are associated (or correlated) with Alx Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alx Oncology Holdings has no effect on the direction of Abiomed i.e., Abiomed and Alx Oncology go up and down completely randomly.

Pair Corralation between Abiomed and Alx Oncology

Given the investment horizon of 90 days Abiomed is expected to generate 3.66 times more return on investment than Alx Oncology. However, Abiomed is 3.66 times more volatile than Alx Oncology Holdings. It trades about 0.22 of its potential returns per unit of risk. Alx Oncology Holdings is currently generating about -0.19 per unit of risk. If you would invest  25,208  in Abiomed on August 30, 2022 and sell it today you would earn a total of  12,600  from holding Abiomed or generate 49.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
ValuesDaily Returns

Abiomed  vs.  Alx Oncology Holdings

 Performance (%) 
Abiomed Performance
8 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Abiomed are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain primary indicators, Abiomed exhibited solid returns over the last few months and may actually be approaching a breakup point.

Abiomed Price Channel

Alx Oncology Holdings 
Alx Oncology Performance
0 of 100
Over the last 90 days Alx Oncology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2022. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Alx Oncology Price Channel

Abiomed and Alx Oncology Volatility Contrast

   Predicted Return Density   

Pair Trading with Abiomed and Alx Oncology

The main advantage of trading using opposite Abiomed and Alx Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abiomed position performs unexpectedly, Alx Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will offset losses from the drop in Alx Oncology's long position.
Abiomed vs. Abbott Laboratories
Abiomed vs. Medtronic
Abiomed vs. Stryker Corp
Abiomed vs. Boston Scientific Corp
The idea behind Abiomed and Alx Oncology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Alx Oncology vs. Vertex Pharmaceutic
Alx Oncology vs. Regeneron Pharmaceuticals
Alx Oncology vs. Siemens Ag ADR
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance